The United States is predicted to dominate the CRISPR and Cas Gene Industry, reaching a staggering US$9.4 billion by 2033 according to Future Market Insights (FMI). This dominance can be attributed to several key factors that position the US as a prime market for this revolutionary technology. Future Market Insights (FMI) reports that the global …